(Q44777356)

6 December 2017

title

Dinitrochlorobenzene skin testing predicts response to hepatitis B vaccine in dialysis patients (English)

1 reference

6 December 2017

0 references

1 reference

S P Bramwell

1

1 reference

6 December 2017

D J Tsakiris

2

1 reference

6 December 2017

J D Briggs

3

1 reference

6 December 2017

E A Follett

4

1 reference

6 December 2017

J Stewart

5

1 reference

6 December 2017

D L McWhinnie

6

1 reference

6 December 2017

M A Watson

7

1 reference

6 December 2017

D N Hamilton

8

1 reference

6 December 2017

B J Junor

9

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 June 1985

1 reference

6 December 2017

1 reference

6 December 2017

volume

1

1 reference

6 December 2017

issue

8443

1 reference

6 December 2017

page(s)

1412-1415

1 reference

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991844-6

7 January 2021

Active hepatitis B vaccination of dialysis patients and medical staff

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991844-6

7 January 2021

Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff. Double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991844-6

7 January 2021

Hepatitis B Vaccine in Health Care Personnel: Safety, lmmunogenicity, and Indicators of Efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991844-6

7 January 2021

Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991844-6

7 January 2021

Hepatitis B vaccine: immune responses in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991844-6

7 January 2021

Endogenous cell-mediated immunity, blood transfusion, and outcome of renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991844-6

7 January 2021

An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991844-6

7 January 2021

Immune complexes in hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991844-6

7 January 2021

Cellular immunity and hepatitis-associated, Australia antigen liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991844-6

7 January 2021

Cell-mediated Immunity in Patients Positive for Hepatitis-associated Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991844-6

7 January 2021

Association of Graft Survival with Host Response to Hepatitis B Infection in Patients with Kidney Transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991844-6

7 January 2021

Renal transplantation in patients with Australia antigenemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991844-6

7 January 2021

Long-Term Effect of HbSAntigenemia on Patient Survival after Renal Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991844-6

7 January 2021

10.1016/S0140-6736(85)91844-6

Identifiers

DOI

1 reference

6 December 2017

1 reference